tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

PHMMF Stock Latest News

Pharma Mar’s Zepzelca® Shows Promising Results in Lung Cancer Treatment
Company AnnouncementsPharma Mar’s Zepzelca® Shows Promising Results in Lung Cancer Treatment
5d ago
Pharma Mar SA Reports on Recent Share Buy-Back Activities
PremiumCompany Announcements
Pharma Mar SA Reports on Recent Share Buy-Back Activities
12d ago
PharmaMar Seeks EMA Approval for New Lung Cancer Treatment
PremiumCompany Announcements
PharmaMar Seeks EMA Approval for New Lung Cancer Treatment
18d ago
Pharma Mar SA Updates on Share Buy-Back Program
PremiumCompany Announcements
Pharma Mar SA Updates on Share Buy-Back Program
19d ago
Pharma Mar Gains Approval for Cancer Drug in Argentina
PremiumCompany Announcements
Pharma Mar Gains Approval for Cancer Drug in Argentina
20d ago
Pharma Mar’s Zepzelca® Gains Approval in Argentina for SCLC Treatment
PremiumCompany AnnouncementsPharma Mar’s Zepzelca® Gains Approval in Argentina for SCLC Treatment
20d ago
Pharma Mar S.A. Announces 2025 Shareholders’ Meeting with Key Agenda Items
Premium
Company Announcements
Pharma Mar S.A. Announces 2025 Shareholders’ Meeting with Key Agenda Items
1M ago
Pharma Mar SA Reports Strong Q1 2025 Revenue Growth
Premium
Company Announcements
Pharma Mar SA Reports Strong Q1 2025 Revenue Growth
1M ago
PharmaMar Reports Strong Q1 2025 Financial Growth
PremiumCompany Announcements
PharmaMar Reports Strong Q1 2025 Financial Growth
1M ago
Pharma Mar Announces 2025 Shareholders Meeting with Key Governance Proposals
PremiumCompany Announcements
Pharma Mar Announces 2025 Shareholders Meeting with Key Governance Proposals
1M ago
Is PHMMF a Buy, Before Earnings?
PremiumPre-Earnings
Is PHMMF a Buy, Before Earnings?
2M ago
Pharma Mar SA Reports on Recent Share Buy-Back Activities
PremiumCompany Announcements
Pharma Mar SA Reports on Recent Share Buy-Back Activities
2M ago
Pharma Mar Adjusts Financial Strategy with New Share Buyback Program
PremiumCompany AnnouncementsPharma Mar Adjusts Financial Strategy with New Share Buyback Program
2M ago
Pharma Mar’s Credit Rating Maintained at ‘BB+’
Premium
Company Announcements
Pharma Mar’s Credit Rating Maintained at ‘BB+’
2M ago
Pharma Mar Partners with Merck for Japanese Launch of Cancer Drug
Premium
Company Announcements
Pharma Mar Partners with Merck for Japanese Launch of Cancer Drug
2M ago
Pharma Mar Implements Share Delivery Plan to Boost Employee Engagement
PremiumCompany Announcements
Pharma Mar Implements Share Delivery Plan to Boost Employee Engagement
2M ago
Sylentis Secures 21.1 Million Euro Grant for RNA Drug Production
PremiumCompany Announcements
Sylentis Secures 21.1 Million Euro Grant for RNA Drug Production
2M ago
PharmaMar Proposes 23% Dividend Increase Amid Strong Financial Performance
PremiumCompany Announcements
PharmaMar Proposes 23% Dividend Increase Amid Strong Financial Performance
2M ago
PHMMF Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
PHMMF Upcoming Earnings Report: What to Expect?
3M ago
Pharma Mar SA Reports Strong 2024 Financial Results
PremiumCompany AnnouncementsPharma Mar SA Reports Strong 2024 Financial Results
3M ago
Pharma Mar Releases 2024 Director Remuneration Report
Premium
Company Announcements
Pharma Mar Releases 2024 Director Remuneration Report
3M ago
PharmaMar SA Reports Strong Financial Growth in 2024
Premium
Company Announcements
PharmaMar SA Reports Strong Financial Growth in 2024
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >